Hospira, Inc.  

(Public, NYSE:HSP)   Watch this stock  
+0.01 (0.01%)
Aug 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 89.91 - 89.96
52 week 46.56 - 90.63
Open 89.96
Vol / Avg. 2.59M/1.61M
Mkt cap 15.55B
P/E 37.69
Div/yield     -
EPS 2.39
Shares 172.93M
Beta 0.94
Inst. own 79%
Nov 4, 2015
Q3 2015 Hospira Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jul 29, 2015
Q2 2015 Hospira Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 12.15% 7.09%
Operating margin 18.47% 10.45%
EBITD margin - 18.27%
Return on average assets 8.65% 4.93%
Return on average equity 16.51% 10.58%
Employees 19,000 -
CDP Score - 58 E


275 N Field Dr
LAKE FOREST, IL 60045-2579
United States - Map
+1-847-9376472 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Officers and directors

F. Michael Ball Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Thomas E. Werner Senior Vice President - Finance, Chief Financial Officer
Age: 57
Bio & Compensation  - Reuters
David J. Endicott President of Hospira Medical Devices
Age: 50
Bio & Compensation  - Reuters
Kenneth F. Meyers Senior Vice President, Chief Human Resource Officer
Age: 53
Bio & Compensation  - Reuters
Mary A. Gendron Senior Vice President, Chief Information Officer
Age: 49
Bio & Compensation  - Reuters
Sumant Ramachandra M.D., Ph.D. Senior Vice President, Chief Scientific Officer
Age: 46
Bio & Compensation  - Reuters
Royce R. Bedward Senior Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Brian J. Smith Senior Vice President, Special Counsel
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard John Davies Senior Vice President, Chief Commercial Officer
Age: 53
Bio & Compensation  - Reuters
Zena G. Kaufman Senior Vice President - Quality
Age: 58
Bio & Compensation  - Reuters